Glaukos Total Assets 2014-2024 | GKOS
Glaukos total assets from 2014 to 2024. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Glaukos total assets for the quarter ending June 30, 2024 were $0.920B, a 3.87% decline year-over-year.
- Glaukos total assets for 2023 were $0.94B, a 6.18% decline from 2022.
- Glaukos total assets for 2022 were $1.002B, a 4.51% decline from 2021.
- Glaukos total assets for 2021 were $1.05B, a 4.4% increase from 2020.
| Glaukos Annual Total Assets (Millions of US $) |
|
|---|---|
| 2023 | $940 |
| 2022 | $1,002 |
| 2021 | $1,050 |
| 2020 | $1,006 |
| 2019 | $818 |
| 2018 | $207 |
| 2017 | $166 |
| 2016 | $134 |
| 2015 | $117 |
| 2014 | $26 |
| 2013 | $31 |
| Glaukos Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2024-06-30 | $920 |
| 2024-03-31 | $933 |
| 2023-12-31 | $940 |
| 2023-09-30 | $949 |
| 2023-06-30 | $957 |
| 2023-03-31 | $973 |
| 2022-12-31 | $1,002 |
| 2022-09-30 | $1,008 |
| 2022-06-30 | $1,031 |
| 2022-03-31 | $1,052 |
| 2021-12-31 | $1,050 |
| 2021-09-30 | $1,064 |
| 2021-06-30 | $1,044 |
| 2021-03-31 | $1,023 |
| 2020-12-31 | $1,006 |
| 2020-09-30 | $995 |
| 2020-06-30 | $996 |
| 2020-03-31 | $780 |
| 2019-12-31 | $818 |
| 2019-09-30 | $307 |
| 2019-06-30 | $302 |
| 2019-03-31 | $228 |
| 2018-12-31 | $207 |
| 2018-09-30 | $191 |
| 2018-06-30 | $171 |
| 2018-03-31 | $163 |
| 2017-12-31 | $166 |
| 2017-09-30 | $153 |
| 2017-06-30 | $146 |
| 2017-03-31 | $138 |
| 2016-12-31 | $134 |
| 2016-09-30 | $129 |
| 2016-06-30 | $124 |
| 2016-03-31 | $116 |
| 2015-12-31 | $117 |
| 2015-09-30 | $118 |
| 2015-06-30 | $128 |
| 2015-03-31 | $28 |
| 2014-12-31 | $26 |
| 2014-09-30 | $0 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | $31 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.357B | $0.315B |
| Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company. Glaukos is focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies designed to treat glaucoma. Glaukos developed Micro Invasive Glaucoma Surgery to serve as an alternative to the traditional glaucoma treatment and management paradigms. The company's iStent platform is the first MIGS device in the United States. Glaukos markets its products through direct sales force in the United States and other countries. It has distribution partners in Europe, the Asia Pacific, Latin America, and internationally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $234.954B | 28.16 |
| Intuitive Surgical (ISRG) | United States | $175.058B | 99.12 |
| Alcon (ALC) | Switzerland | $48.180B | 33.92 |
| IQVIA Holdings (IQV) | United States | $45.858B | 25.99 |
| Edwards Lifesciences (EW) | United States | $42.144B | 27.01 |
| IDEXX Laboratories (IDXX) | United States | $39.616B | 47.66 |
| DexCom (DXCM) | United States | $27.786B | 39.62 |
| STERIS (STE) | Ireland | $23.777B | 27.74 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.808B | 0.00 |
| Waters (WAT) | United States | $20.560B | 30.65 |
| Hologic (HOLX) | United States | $18.870B | 20.52 |
| Sysmex ADR (SSMXY) | Japan | $12.134B | 38.05 |
| Teleflex (TFX) | United States | $11.552B | 17.96 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.379B | 12.76 |
| Globus Medical (GMED) | United States | $9.844B | 27.54 |
| Penumbra (PEN) | United States | $7.859B | 81.58 |
| Masimo (MASI) | United States | $6.252B | 33.48 |
| TransMedics (TMDX) | United States | $5.606B | 240.09 |
| Integer Holdings (ITGR) | United States | $4.361B | 25.50 |
| PROCEPT BioRobotics (PRCT) | United States | $4.103B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.848B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.736B | 16.05 |
| Elekta AB (EKTAY) | Sweden | $2.601B | 21.19 |
| Inari Medical (NARI) | United States | $2.519B | 0.00 |
| Veracyte (VCYT) | United States | $2.423B | 150.24 |
| Nihon Kohden (NHNKY) | Japan | $2.287B | 14.23 |
| RxSight (RXST) | United States | $2.086B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.578B | 7.19 |
| OPKO Health (OPK) | United States | $1.172B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.142B | 0.00 |
| Artivion (AORT) | United States | $1.137B | 104.38 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.113B | 19.85 |
| Silk Road Medical (SILK) | United States | $1.102B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.969B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.774B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.723B | 18.26 |
| Paragon 28 (FNA) | United States | $0.695B | 0.00 |
| SiBone (SIBN) | United States | $0.693B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.666B | 0.00 |
| IRadimed (IRMD) | United States | $0.595B | 32.16 |
| AxoGen (AXGN) | United States | $0.576B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.384B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.373B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.358B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.341B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.325B | 9.92 |
| Delcath Systems (DCTH) | United States | $0.306B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.300B | 0.00 |
| Inogen (INGN) | United States | $0.291B | 0.00 |
| NeuroPace (NPCE) | United States | $0.231B | 0.00 |
| Nevro (NVRO) | United States | $0.231B | 0.00 |
| Accuray (ARAY) | United States | $0.216B | 0.00 |
| CVRx (CVRX) | United States | $0.215B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.187B | 13.09 |
| Atossa Genetics (ATOS) | United States | $0.172B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.171B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.141B | 0.00 |
| 908 Devices (MASS) | United States | $0.137B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.134B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.107B | 15.90 |
| Monogram Orthopaedics (MGRM) | United States | $0.087B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.070B | 0.00 |
| InspireMD (NSPR) | Israel | $0.069B | 0.00 |
| Envoy Medical (COCH) | United States | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.058B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.056B | 0.00 |
| LENSAR (LNSR) | United States | $0.054B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.043B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.039B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.037B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| ReWalk Robotics (LFWD) | United States | $0.030B | 0.00 |
| Neuronetics (STIM) | United States | $0.027B | 0.00 |
| Spectral AI (MDAI) | United States | $0.025B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.021B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.017B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.015B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.015B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |